Is deep brain stimulation a treatment option for anorexia nervosa?

Marloes S Oudijn, Jitschak G Storosum, Elise Nelis, Damiaan Denys, Marloes S Oudijn, Jitschak G Storosum, Elise Nelis, Damiaan Denys

Abstract

Anorexia nervosa (AN) is a severe psychiatric disorder with high rates of morbidity, comorbidity and mortality, which in a subset of patients (21%) takes on a chronic course. Since an evidence based treatment for AN is scarce, it is crucial to investigate new treatment options, preferably focused on influencing the underlying neurobiological mechanisms of AN. The objective of the present paper was to review the evidence for possible neurobiological correlates of AN, and to hypothesize about potential targets for Deep brain stimulation (DBS) as a treatment for chronic, therapy-refractory AN. One avenue for exploring new treatment options based on the neurobiological correlates of AN, is the search for symptomatologic and neurobiologic parallels between AN and other compulsivity- or reward-related disorders. As in other compulsive disorders, the fronto-striatal circuitry, in particular the insula, the ventral striatum (VS) and the prefrontal, orbitofrontal, temporal, parietal and anterior cingulate cortices, are likely to be implicated in the neuropathogenesis of AN. In this paper we will review the few available cases in which DBS has been performed in patients with AN (either as primary diagnosis or as comorbid condition). Given the overlap in symptomatology and neurocircuitry between reward-related disorders such as obsessive compulsive disorder (OCD) and AN, and the established efficacy of accumbal DBS in OCD, we hypothesize that DBS of the nucleus accumbens (NAc) and other areas associated with reward, e.g. the anterior cingulated cortex (ACC), might be an effective treatment for patients with chronic, treatment refractory AN, providing not only weight restoration, but also significant and sustained improvement in AN core symptoms and associated comorbidities and complications. Possible targets for DBS in AN are the ACC, the ventral anterior limb of the capsula interna (vALIC) and the VS. We suggest conducting larger efficacy studies that also explore the functional effects of DBS in AN.

References

    1. Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 2003;34:383–396. doi: 10.1002/eat.10222.
    1. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 2006;19:389–394. doi: 10.1097/01.yco.0000228759.95237.78.
    1. Keski-Rahkonen A, Hoek HW, Susser ES, Linna MS, Sihvola E, Raevuori A. et al.Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry. 2007;164:1259–1265. doi: 10.1176/appi.ajp.2007.06081388.
    1. Jacobi C, Hayward C, Agras WS. Coming to terms with risk factors for eating disorders: application of risk terminology and suggestions for a general taxonomy. Psychol Bull. 2004;130(Agras WS):19–65.
    1. Katzman DK. Medical complications in adolescents with anorexia nervosa: a review of the literature. Int J Eat Disord. 2005;37(Suppl):S52–S59.
    1. Treasure J, Claudino AM, Zucker N. Eating disorders. Lancet. 2010;375:583–593. doi: 10.1016/S0140-6736(09)61748-7.
    1. Herpertz-Dahlmann B. Adolescent eating disorders: definitions, symptomatology, epidemiology and comorbidity. Child Adolesc Psychiatr Clin N Am. 2009;18:31–47. doi: 10.1016/j.chc.2008.07.005.
    1. Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68:724–731. doi: 10.1001/archgenpsychiatry.2011.74.
    1. Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry. 1995;152:1073–1074.
    1. Zipfel S, Lowe B, Reas DL, Deter HC, Herzog W. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet. 2000;355:721–722. doi: 10.1016/S0140-6736(99)05363-5.
    1. Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry. 2002;159:1284–1293. doi: 10.1176/appi.ajp.159.8.1284.
    1. Millar HR, Wardell F, Vyvyan JP, Naji SA, Prescott GJ, Eagles JM. Anorexia nervosa mortality in Northeast Scotland, 1965–1999. Am J Psychiatry. 2005;162:753–757. doi: 10.1176/appi.ajp.162.4.753.
    1. Birmingham CL, Su J, Hlynsky JA, Goldner EM, Gao M. The mortality rate from anorexia nervosa. Int J Eat Disord. 2005;38:143–146. doi: 10.1002/eat.20164.
    1. Fichter MM, Quadflieg N, Hedlund S. Twelve-year course and outcome predictors of anorexia nervosa. Int J Eat Disord. 2006;39:87–100. doi: 10.1002/eat.20215.
    1. Papadopoulos FC, Ekbom A, Brandt L, Ekselius L. Excess mortality, causes of death and prognostic factors in anorexia nervosa. Br J Psychiatry. 2009;194:10–17. doi: 10.1192/bjp.bp.108.054742.
    1. Berkman ND, Lohr KN, Bulik CM. Outcomes of eating disorders: a systematic review of the literature. Int J Eat Disord. 2007;40:293–309. doi: 10.1002/eat.20369.
    1. Herzog DB, Greenwood DN, Dorer DJ, Flores AT, Ekeblad ER, Richards A. et al.Mortality in eating disorders: a descriptive study. Int J Eat Disord. 2000;28:20–26. doi: 10.1002/(SICI)1098-108X(200007)28:1<20::AID-EAT3>;2-X.
    1. Steinhausen HC. Outcome of eating disorders. Child Adolesc Psychiatr Clin N Am. 2009;18:225–242. doi: 10.1016/j.chc.2008.07.013.
    1. Morris J, Twaddle S. Anorexia nervosa. BMJ. 2007;334:894–898. doi: 10.1136/.
    1. Guarda AS. Treatment of anorexia nervosa: insights and obstacles. Physiol Behav. 2008;94:113–120. doi: 10.1016/j.physbeh.2007.11.020.
    1. Agras WS, Robinson AH. Forty years of progress in the treatment of the eating disorders. Nord J Psychiatry. 2008;62(Suppl 47):19–24.
    1. Focker M, Knoll S, Hebebrand J. Anorexia nervosa. Eur Child Adolesc Psychiatry. 2013;22(Suppl 1):S29–S35.
    1. Bulik CM, Berkman ND, Brownley KA, Sedway JA, Lohr KN. Anorexia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord. 2007;40:310–320. doi: 10.1002/eat.20367.
    1. Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C. et al.Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001;49:644–652. doi: 10.1016/S0006-3223(00)01013-1.
    1. Mitchell JE, De ZM, Roerig JL. Drug therapy for patients with eating disorders. Curr Drug Targets CNS Neurol Disord. 2003;2:17–29. doi: 10.2174/1568007033338850.
    1. Halmi KA, Eckert E, LaDu TJ, Cohen J. Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry. 1986;43:177–181. doi: 10.1001/archpsyc.1986.01800020087011.
    1. Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF. et al.Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 1985;5:10–16.
    1. McKnight RF, Park RJ. Atypical antipsychotics and anorexia nervosa: a review. Eur Eat Disord Rev. 2010;18:10–21. doi: 10.1002/erv.988.
    1. Bissada H, Tasca GA, Barber AM, Bradwejn J. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2008;165:1281–1288. doi: 10.1176/appi.ajp.2008.07121900.
    1. Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P. et al.Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol. 2007;22:197–204. doi: 10.1097/YIC.0b013e328080ca31.
    1. Attia E, Kaplan AS, Walsh BT, Gershkovich M, Yilmaz Z, Musante D. et al.Olanzapine versus placebo for out-patients with anorexia nervosa. Psychol Med. 2011;41:2177–2182. doi: 10.1017/S0033291711000390.
    1. Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM. et al.A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. J Child Adolesc Psychopharmacol. 2011;21:207–212. doi: 10.1089/cap.2010.0139.
    1. Brewerton TD. Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials. Curr Psychiatry Rep. 2012;14:398–405. doi: 10.1007/s11920-012-0287-6.
    1. Wilson GT, Shafran R. Eating disorders guidelines from NICE. Lancet. 2005;365:79–81. doi: 10.1016/S0140-6736(04)17669-1.
    1. Beumont P, Hay P, Beumont D, Birmingham L, Derham H, Jordan A. et al.Australian and New Zealand clinical practice guidelines for the treatment of anorexia nervosa. Aust N Z J Psychiatry. 2004;38:659–670.
    1. Couturier J, Lock J. What is recovery in adolescent anorexia nervosa? Int J Eat Disord. 2006;39:550–555. doi: 10.1002/eat.20309.
    1. Strober M, Freeman R, Morrell W. The long-term course of severe anorexia nervosa in adolescents: survival analysis of recovery, relapse, and outcome predictors over 10–15 years in a prospective study. Int J Eat Disord. 1997;22:339–360. doi: 10.1002/(SICI)1098-108X(199712)22:4<339::AID-EAT1>;2-N.
    1. Herzog DB, Dorer DJ, Keel PK, Selwyn SE, Ekeblad ER, Flores AT. et al.Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow-up study. J Am Acad Child Adolesc Psychiatry. 1999;38:829–837. doi: 10.1097/00004583-199907000-00012.
    1. Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci. 2009;10:573–584. doi: 10.1038/nrn2682.
    1. Bulik CM, Slof-Op’t Landt MC, van Furth EF, Sullivan PF. The genetics of anorexia nervosa. Annu Rev Nutr. 2007;27:263–275. doi: 10.1146/annurev.nutr.27.061406.093713.
    1. Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry. 2006;63:305–312. doi: 10.1001/archpsyc.63.3.305.
    1. Scherag S, Hebebrand J, Hinney A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry. 2010;19:211–226.
    1. Slof-Op ’t Landt MC, van Furth EF, Meulenbelt I, Slagboom PE, Bartels M, Boomsma DI. et al.Eating disorders: from twin studies to candidate genes and beyond. Twin Res Hum Genet. 2005;8:467–482.
    1. Klump KL, Wonderlich S, Lehoux P, Lilenfeld LR, Bulik CM. Does environment matter? A review of nonshared environment and eating disorders. Int J Eat Disord. 2002;31:118–135. doi: 10.1002/eat.10024.
    1. Pinheiro AP, Root T, Bulik CM. The genetics of anorexia nervosa: current findings and future perspectives. Int J Child Adolesc health. 2009;2:153–164.
    1. Lilenfeld LR, Wonderlich S, Riso LP, Crosby R, Mitchell J. Eating disorders and personality: a methodological and empirical review. Clin Psychol Rev. 2006;26:299–320. doi: 10.1016/j.cpr.2005.10.003.
    1. Halmi KA, Tozzi F, Thornton LM, Crow S, Fichter MM, Kaplan AS. et al.The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders. Int J Eat Disord. 2005;38:371–374. doi: 10.1002/eat.20190.
    1. Stice E. Risk and maintenance factors for eating pathology: a meta-analytic review. Psychol Bull. 2002;128:825–848.
    1. Kaye WH, Wagner A, Fudge JL, Paulus M. Neurocircuity of eating disorders. Curr Top Behav Neurosci. 2011;6:37–57.
    1. Keating C, Tilbrook AJ, Rossell SL, Enticott PG, Fitzgerald PB. Reward processing in anorexia nervosa. Neuropsychologia. 2012;50:567–575. doi: 10.1016/j.neuropsychologia.2012.01.036.
    1. Keating C. Theoretical perspective on anorexia nervosa: the conflict of reward. Neurosci Biobehav Rev. 2010;34:73–79. doi: 10.1016/j.neubiorev.2009.07.004.
    1. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav. 2008;94:121–135. doi: 10.1016/j.physbeh.2007.11.037.
    1. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L. et al.Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry. 2005;62:1032–1041. doi: 10.1001/archpsyc.62.9.1032.
    1. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis CA. et al.Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry. 2007;61:1090–1099. doi: 10.1016/j.biopsych.2006.07.018.
    1. Bailer UF, Kaye WH. Serotonin: imaging findings in eating disorders. Curr Top Behav Neurosci. 2011;6:59–79.
    1. Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M. et al.Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. Int J Eat Disord. 2003;33:257–267. doi: 10.1002/eat.10135.
    1. Kaye WH, Frank GK, McConaha C. Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacology. 1999;21:503–506. doi: 10.1016/S0893-133X(99)00053-6.
    1. Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC. et al.Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry. 2005;58:908–912. doi: 10.1016/j.biopsych.2005.05.003.
    1. Bergen AW, Yeager M, Welch RA, Haque K, Ganjei JK, van den Bree MB. et al.Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology. 2005;30:1703–1710. doi: 10.1038/sj.npp.1300719.
    1. Lawrence AD, Dowson J, Foxall GL, Summerfield R, Robbins TW, Sahakian BJ. Impaired visual discrimination learning in anorexia nervosa. Appetite. 2003;40:85–89. doi: 10.1016/S0195-6663(02)00138-1.
    1. Van Dijk A, Klompmakers A, Denys D. Role of serotonin in obsessive-compulsive disorder. Future Neurol. 2008;3:589–603. doi: 10.2217/14796708.3.5.589.
    1. Katzman DK, Lambe EK, Mikulis DJ, Ridgley JN, Goldbloom DS, Zipursky RB. Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr. 1996;129:794–803. doi: 10.1016/S0022-3476(96)70021-5.
    1. Herholz K. Neuroimaging in anorexia nervosa. Psychiatry Res. 1996;62:105–110. doi: 10.1016/0165-1781(96)02990-3.
    1. Van den Eynde F, Suda M, Broadbent H, Guillaume S, Van den Eynde M, Steiger H. et al.Structural magnetic resonance imaging in eating disorders: a systematic review of voxel-based morphometry studies. Eur Eat Disord Rev. 2012;20:94–105. doi: 10.1002/erv.1163.
    1. Naruo T, Nakabeppu Y, Deguchi D, Nagai N, Tsutsui J, Nakajo M. et al.Decreases in blood perfusion of the anterior cingulate gyri in Anorexia Nervosa Restricters assessed by SPECT image analysis. BMC Psychiatry. 2001;1:2. doi: 10.1186/1471-244X-1-2.
    1. Delvenne V, Goldman S, V De M, V De M, Lotstra F. Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int J Eat Disord. 1999;25:29–37. doi: 10.1002/(SICI)1098-108X(199901)25:1<29::AID-EAT4>;2-#.
    1. Uher R, Murphy T, Brammer MJ, Dalgleish T, Phillips ML, Ng VW. et al.Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry. 2004;161:1238–1246. doi: 10.1176/appi.ajp.161.7.1238.
    1. Herholz K, Krieg JC, Emrich HM, Pawlik G, Beil C, Pirke KM. et al.Regional cerebral glucose metabolism in anorexia nervosa measured by positron emission tomography. Biol Psychiatry. 1987;22:43–51. doi: 10.1016/0006-3223(87)90128-4.
    1. Santel S, Baving L, Krauel K, Munte TF, Rotte M. Hunger and satiety in anorexia nervosa: fMRI during cognitive processing of food pictures. Brain Res. 2006;1114:138–148. doi: 10.1016/j.brainres.2006.07.045.
    1. Fladung AK, Gron G, Grammer K, Herrnberger B, Schilly E, Grasteit S. et al.A neural signature of anorexia nervosa in the ventral striatal reward system. Am J Psychiatry. 2010;167:206–212. doi: 10.1176/appi.ajp.2009.09010071.
    1. Nozoe S, Naruo T, Yonekura R, Nakabeppu Y, Soejima Y, Nagai N. et al.Comparison of regional cerebral blood flow in patients with eating disorders. Brain Res Bull. 1995;36:251–255. doi: 10.1016/0361-9230(94)00199-B.
    1. Van KK, Gerard N, Van LK, Casteels C, Pieters G, Gabriels L. et al.Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies. J Psychiatr Res. 2009;43:1133–1145. doi: 10.1016/j.jpsychires.2009.04.005.
    1. Van den Eynde F, Treasure J. Neuroimaging in eating disorders and obesity: implications for research. Child Adolesc Psychiatr Clin N Am. 2009;18:95–115. doi: 10.1016/j.chc.2008.07.016.
    1. Frank GK, Bailer UF, Henry S, Wagner A, Kaye WH. Neuroimaging studies in eating disorders. CNS Spectr. 2004;9:539–548.
    1. Gordon I, Lask B, Bryant-Waugh R, Christie D, Timimi S. Childhood-onset anorexia nervosa: towards identifying a biological substrate. Int J Eat Disord. 1997;22:159–165. doi: 10.1002/(SICI)1098-108X(199709)22:2<159::AID-EAT7>;2-E.
    1. Rastam M, Bjure J, Vestergren E, Uvebrant P, Gillberg IC, Wentz E. et al.Regional cerebral blood flow in weight-restored anorexia nervosa: a preliminary study. Dev Med Child Neurol. 2001;43:239–242. doi: 10.1017/S0012162201000457.
    1. Pietrini F, Castellini G, Ricca V, Polito C, Pupi A, Faravelli C. Functional neuroimaging in anorexia nervosa: a clinical approach. Eur Psychiatry. 2011;26:176–182.
    1. Uher R, Brammer MJ, Murphy T, Campbell IC, Ng VW, Williams SC. et al.Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry. 2003;54:934–942. doi: 10.1016/S0006-3223(03)00172-0.
    1. Wagner A, Aizenstein H, Venkatraman VK, Fudge J, May JC, Mazurkewicz L. et al.Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry. 2007;164:1842–1849. doi: 10.1176/appi.ajp.2007.07040575.
    1. Zastrow A, Kaiser S, Stippich C, Walther S, Herzog W, Tchanturia K. et al.Neural correlates of impaired cognitive-behavioral flexibility in anorexia nervosa. Am J Psychiatry. 2009;166:608–616. doi: 10.1176/appi.ajp.2008.08050775.
    1. Wagner A, Aizenstein H, Mazurkewicz L, Fudge J, Frank GK, Putnam K. et al.Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology. 2008;33:513–523. doi: 10.1038/sj.npp.1301443.
    1. Bush G, Vogt BA, Holmes J, Dale AM, Greve D, Jenike MA. et al.Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci U S A. 2002;99:523–528. doi: 10.1073/pnas.012470999.
    1. Kampe J, Tschop MH, Hollis JH, Oldfield BJ. An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance. Eur J Neurosci. 2009;30:415–430. doi: 10.1111/j.1460-9568.2009.06818.x.
    1. Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B. et al.Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2010;67:110–116. doi: 10.1016/j.biopsych.2009.09.013.
    1. Denys D, Mantione M. Deep brain stimulation in obsessive-compulsive disorder. Prog Brain Res. 2009;175:419–427.
    1. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N. et al.Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33:368–377. doi: 10.1038/sj.npp.1301408.
    1. Greenberg BD, Gabriels LA, Malone DA Jr, Rezai AR, Friehs GM, Okun MS. et al.Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010;15:64–79. doi: 10.1038/mp.2008.55.
    1. Rauch SL. Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurg Clin N Am. 2003;14:213-viii.
    1. Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF. et al.Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry. 2005;57:510–516. doi: 10.1016/j.biopsych.2004.11.042.
    1. Anderson RJ, Frye MA, Abulseoud OA, Lee KH, McGillivray JA, Berk M. et al.Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev. 2012;36:1920–1933. doi: 10.1016/j.neubiorev.2012.06.001.
    1. Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, Van WG, De KB. et al.Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci. 2013;16:386–387. doi: 10.1038/nn.3344.
    1. Denys D. Deep brain stimulation in psychiatric disorders. Ned Tijdschr Geneeskd. 2008;152:2330–2335.
    1. Carmody JT, Vibber FL. Anorexia nervosa treated by prefrontal lobotomy. Ann Intern Med. 1952;36:647–652.
    1. Drury MO. An emergency leucotomy. Br Med J. 1950;2:609. doi: 10.1136/bmj.2.4679.609.
    1. Sargant W. Leucotomy in psychosomatic disorders. Lancet. 1951;2:87–91.
    1. Sifneos PE. A case of anorexia nervosa treated successfully by leucotomy. Am J Psychiatry. 1952;109:356–360.
    1. Glazebrook AJ, Prosen H. Compulsive neurosis with cachexia. Can Med Assoc J. 1956;75:40–42.
    1. Crisp AH, Kalucy RS. The effect of leucotomy in intractable adolescent weight phobia (primary anorexia nervosa) Postgrad Med J. 1973;49:883–893. doi: 10.1136/pgmj.49.578.883.
    1. Morgan JF, Crisp AH. Use of leucotomy for intractable anorexia nervosa: a long-term follow-up study. Int J Eat Disord. 2000;27:249–258. doi: 10.1002/(SICI)1098-108X(200004)27:3<249::AID-EAT1>;2-K.
    1. Zamboni R, Larach V, Poblete M, Mancini R, Mancini H, Charlin V. et al.Dorsomedial thalamotomy as a treatment for terminal anorexia: a report of two cases. Acta Neurochir Suppl (Wien) 1993;58:34–35.
    1. Lipsman N, Woodside DB, Giacobbe P, Lozano AM. Neurosurgical treatment of anorexia nervosa: review of the literature from leucotomy to deep brain stimulation. Eur Eat Disord Rev. 2013. Jul 19. doi:10.1002/erv.2246. [Epub ahead of print]
    1. Barbier J, Gabriels L, Van LK, Nuttin B. Successful anterior capsulotomy in comorbid anorexia nervosa and obsessive-compulsive disorder: case report. Neurosurgery. 2011;69:E745–E751. doi: 10.1227/NEU.0b013e31821964d2.
    1. Israel M, Steiger H, Kolivakis T, McGregor L, Sadikot AF. Deep brain stimulation in the subgenual cingulate cortex for an intractable eating disorder. Biol Psychiatry. 2010;67:e53–e54. doi: 10.1016/j.biopsych.2009.11.016.
    1. McLaughlin NC, Didie ER, Machado AG, Haber SN, Eskandar EN, Greenberg BD. Improvements in anorexia symptoms after deep brain stimulation for intractable obsessive-compulsive disorder. Biol Psychiatry. 2012;73:e29–e31.
    1. Wu H, Van Dyck-Lippens PJ, Santegoeds R, Van KK, Gabriels L, Lin G. et al.Deep-brain stimulation for anorexia nervosa. World Neurosurg. 2012;80:S29.e1–S29.
    1. Lipsman N, Woodside DB, Giacobbe P, Hamani C, Carter JC, Norwood SJ. et al.Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet. 2013;381:1361–1370. doi: 10.1016/S0140-6736(12)62188-6.
    1. Altman SE, Shankman SA. What is the association between obsessive-compulsive disorder and eating disorders? Clin Psychol Rev. 2009;29:638–646. doi: 10.1016/j.cpr.2009.08.001.
    1. Denys D. Obsessionality & compulsivity: a phenomenology of obsessive-compulsive disorder. Philos Ethics Humanit Med. 2011;6:3. doi: 10.1186/1747-5341-6-3.
    1. Friederich HC, Herzog W. Cognitive-behavioral flexibility in anorexia nervosa. Curr Top Behav Neurosci. 2011;6:111–123.
    1. Swinbourne JM, Touyz SW. The co-morbidity of eating disorders and anxiety disorders: a review. Eur Eat Disord Rev. 2007;15:253–274. doi: 10.1002/erv.784.
    1. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry. 2004;161:2215–2221. doi: 10.1176/appi.ajp.161.12.2215.
    1. Godart N, Berthoz S, Perdereau F, Jeammet P. Comorbidity of anxiety with eating disorders and OCD. Am J Psychiatry. 2006;163:326–329.
    1. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004;132:69–79. doi: 10.1016/j.pscychresns.2004.07.001.
    1. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32:525–549. doi: 10.1016/j.neubiorev.2007.09.005.
    1. Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry. 2010;67:701–711. doi: 10.1001/archgenpsychiatry.2010.70.
    1. Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg. 2012;116:84–94. doi: 10.3171/2011.8.JNS101407.
    1. Seller CA, Ravalia A. Anaesthetic implications of anorexia nervosa. Anaesthesia. 2003;58:437–443. doi: 10.1046/j.1365-2044.2003.03130.x.
    1. Khan LU, Ahmed J, Khan S, Macfie J. Refeeding syndrome: a literature review. Gastroenterol Res Pract. 2011;2011 doi:10.1155/2011/410971. [Epub 2010 Aug 25]

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi